NOVEL PROTEIN KINASE INHIBITORS
The present disclosure describes novel protein kinase inhibitors and methods for preparing them. The pharmaceutical compositions comprising such protein kinase inhibitors and methods of using them for treating cancer and other diseases, conditions, or disorders, which respond to the inhibition of ep...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
25.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure describes novel protein kinase inhibitors and methods for preparing them. The pharmaceutical compositions comprising such protein kinase inhibitors and methods of using them for treating cancer and other diseases, conditions, or disorders, which respond to the inhibition of epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK) activity, or a combination thereof, are also described. |
---|---|
Bibliography: | Application Number: US202117917119 |